VentriPoint Diagnostics

ON - Toronto

Diagnostics

Website LinkedIn

Focus: Ejection Fraction Measurement

VentriPoint Diagnostics is a life sciences company focused on Ejection Fraction Measurement.

Funding Stage

PUBLIC

Open Jobs

0

Products & Portfolio (1)

LOE Approaching

ORAL · TABLET, EXTENDED RELEASE

mechanism(s) by which levetiracetam exerts its antiepileptic effect is unknown. A saturable and stereoselective neuronal binding site in rat brain tissue has been described for levetiracetam. Experimental data indicate that this binding site is the synaptic vesicle protein SV2A, thought to be involved in the regulation of vesicle exocytosis. Although the molecular significance of levetiracetam binding to synaptic vesicle protein SV2A is not understood, levetiracetam and related analogs showed a rank order of affinity for SV2A which correlated with the potency of their antiseizure activity in audiogenic seizure-prone mice. These findings suggest that the interaction of levetiracetam with the SV2A protein may contribute to the antiepileptic mechanism of action of the drug.

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

Portfolio: 1 approved product

Portfolio Health

LOE Approaching1 (100%)

1 total products